Literature DB >> 15102603

Antimicrobial peptides and the skin.

Antoanella Bardan1, Victor Nizet, Richard L Gallo.   

Abstract

In recent years, hundreds of naturally occurring peptide antibiotics have been discovered based on their ability to inhibit the growth of microbial pathogens. These antimicrobial peptides (AMPs) participate in the innate immune response by providing a rapid first-line defence against infection. This review discusses the biology and clinical relevance of the two major families of AMPs, cathelicidins and defensins, with emphasis on their function in mammalian skin and their association with skin pathology. Current evidence shows that cathelicidins and defensins act as both natural antibiotics and as signalling molecules that activate host cell processes involved in immune defence and tissue repair. Alterations in the expression pattern of AMPs have been associated with a variety of pathological processes. Ongoing and future studies are likely to implicate AMPs in several unexplained human inflammatory disorders and to provide novel therapeutic approaches for the treatment of these diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102603     DOI: 10.1517/14712598.4.4.543

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  22 in total

1.  Interleukin-17A (IL-17A) and IL-17F Are Critical for Antimicrobial Peptide Production and Clearance of Staphylococcus aureus Nasal Colonization.

Authors:  Nathan K Archer; Nithin D Adappa; James N Palmer; Noam A Cohen; Jan M Harro; Steven K Lee; Lloyd S Miller; Mark E Shirtliff
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 2.  Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.

Authors:  Mohamed Zaiou
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

3.  [Antimicrobial peptides. A perspective for the treatment of chronic wounds?].

Authors:  A Körber; S Grabbe; J Dissemond
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

4.  Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.

Authors:  Manjusha M Kulkarni; Joseph Barbi; W Robert McMaster; Richard L Gallo; Abhay R Satoskar; Bradford S McGwire
Journal:  Cell Microbiol       Date:  2011-04-28       Impact factor: 3.715

5.  Crystal structure and functional mechanism of a human antimicrobial membrane channel.

Authors:  Chen Song; Conrad Weichbrodt; Evgeniy S Salnikov; Marek Dynowski; Björn O Forsberg; Burkhard Bechinger; Claudia Steinem; Bert L de Groot; Ulrich Zachariae; Kornelius Zeth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

6.  Human neutrophil peptide-1 decreases during ageing in selected Mexican population.

Authors:  Bruno Rivas-Santiago; Julio E Castañeda-Delgado; Jeny de Haro-Acosta; Flor Torres-Juarez; Isabel Frausto-Lujan; Paulina Marin-Luevano; Roberto González-Amaro; Jose A Enciso-Moreno
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

7.  The rate of wound healing is increased in psoriasis.

Authors:  V B Morhenn; T E Nelson; D L Gruol
Journal:  J Dermatol Sci       Date:  2013-06-12       Impact factor: 4.563

8.  The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury.

Authors:  Katherine A Radek; Belen Lopez-Garcia; Melanie Hupe; Ingrid R Niesman; Peter M Elias; Laurent Taupenot; Sushil K Mahata; Daniel T O'Connor; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2008-01-10       Impact factor: 8.551

9.  Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcoma.

Authors:  Hanan Fathy; Maha M Amin; Abdel-Hady El-Gilany
Journal:  F1000Res       Date:  2012-10-26

10.  Dipeptides Inhibit Melanin Synthesis in Mel-Ab Cells through Down-Regulation of Tyrosinase.

Authors:  Hyun-E Lee; Eun-Hyun Kim; Hye-Ryung Choi; Uy Dong Sohn; Hye-Young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Kyoung-Chan Park; Dong-Seok Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.